Calendar

COMPLETEDphase readoutNCT07434258: Dose-Response Association Between Cerclage Wire Number and Infection Risk

Sponsor: Istanbul University. Phase: . Conditions: Femur Fracture, Periprosthetic Fracture of Hip, Periprosthetic Fracture of the Femur, Surgical Site Infection (SSI), Biofilms, Postoperative Complications

full page →ctgov ↗

RECRUITINGphase readoutNCT03889743: Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing

Sponsor: St. Olavs Hospital. Phase: PHASE4. Conditions: Asthma, Inflammation

full page →ctgov ↗

RECRUITINGphase readoutNCT07449715: Respiration From Pleth Validation

Sponsor: Philips Clinical & Medical Affairs Global. Phase: . Conditions: Respiratory Rate Monitoring

full page →ctgov ↗

COMPLETEDphase readoutNCT07694115: Bioequivalence Study to Compare Empagliflozin/ Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg

Sponsor: Humanis Saglık Anonim Sirketi. Phase: PHASE1. Conditions: Type 2 Diabetes Mellitus (T2DM)

full page →ctgov ↗

RECRUITINGphase readoutNCT04379115: Optimization of NIBS for Treatment of Addiction

Sponsor: Case Western Reserve University. Phase: NA. Conditions: Opioid-use Disorder, Chronic Pain

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06208215: RZ358 Treatment for Congenital Hyperinsulinism

Sponsor: Rezolute. Phase: PHASE3. Conditions: Congenital Hyperinsulinism

full page →ctgov ↗

COMPLETEDphase readoutNCT07442825: Evaluating Laser and Piezocision vs. Piezocision Alone on Root Resorption and Gingival Health During Tooth Retraction

Sponsor: Damascus University. Phase: NA. Conditions: Malocclusion, Angle Class II, Division 1

full page →ctgov ↗

WITHHELDphase readoutNCT06762340: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07154576: Central Sensitization Inventory and Symptoms of Pelvic Floor Dysfunctions

Sponsor: Żelazna Medical Centre, LLC. Phase: . Conditions: Pelvic Floor Dysfunctions

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07414589: Brief Alcohol Treatment for Women Veterans in Primary Care

Sponsor: Syracuse VA Medical Center. Phase: NA. Conditions: Alcohol Misuse

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07491068: The Accuracy and Efficacy of Large Language Model Written Hospital Course Summaries

Sponsor: Pavol Jozef Safarik University. Phase: NA. Conditions: Hospitalizations

full page →ctgov ↗

RECRUITINGphase readoutNCT06881368: Phenotypic and Etiological Characterization of Susac Syndrome

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Susac Syndrome

full page →ctgov ↗

TERMINATEDphase readoutNCT04758650: Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis

Sponsor: Universitair Ziekenhuis Brussel. Phase: PHASE2. Conditions: Solid Malignancy Located in the Head and Neck, Cancer, Carotid Stenosis, Atherosclerosis of Artery, Hodgkin Lymphoma, Adult, Non Hodgkin Lymphoma, HLH, Cardiac Sarcoidosis, Sarcoidosis

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07524374: SHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After Immunotherapy

Sponsor: Zhigang Li. Phase: PHASE2. Conditions: ESCC

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07698574: Qiling Yiqi Tablets Plus Antiretroviral Therapy for HIV Immune Non-responders With Lung-Spleen Qi Deficiency

Sponsor: Beijing University of Chinese Medicine. Phase: NA. Conditions: HIV-1 Infection, Acquired Immunodeficiency Syndrome, Immune Reconstitution Failure, Immunological Non-responder, Lung-Spleen Qi Deficiency Syndrome

full page →ctgov ↗

RECRUITINGphase readoutNCT07449091: Adaptability of an Undetectable = Untransmissible Model for HBV

Sponsor: NYU Langone Health. Phase: . Conditions: Chronic Hepatitis b, Viremia

full page →ctgov ↗

RECRUITINGphase readoutNCT01532791: Natural History Study - Mitochondrial Disease

Sponsor: Columbia University. Phase: . Conditions: MELAS or m.3243 A>G Mitochondrial DNA Mutation Carrier

full page →ctgov ↗

COMPLETEDphase readoutNCT07385391: Development of a Novel Algorithm for Real-Time Bedside Assessment of Insulin Resistance in Critically Ill Patients Based on Continuous Glucose Monitoring Data

Sponsor: Chinese Medical Association. Phase: . Conditions: Critical Illness, Metabolism Disorders, Insulin Resistance

full page →ctgov ↗

TERMINATEDphase readoutNCT06511791: An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.

Sponsor: Ferring Pharmaceuticals. Phase: PHASE1. Conditions: Infertility

full page →ctgov ↗

COMPLETEDphase readoutNCT04841174: The Effect of Abdominal Massage on Gastric Problems in Pediatric Intensive Care: A Randomized Controlled Study

Sponsor: Istanbul University - Cerrahpasa. Phase: NA. Conditions: Intensive Care Units, Pediatric, Massage, Nutrition Disorders, Nurse's Role

full page →ctgov ↗

COMPLETEDphase readoutNCT05010018: A Mobile Application to Improve Procurement and Distribution of Healthful Foods & Beverages in Baltimore City

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: Obesity

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04850118: A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP

Sponsor: Beacon Therapeutics. Phase: PHASE2. Conditions: X-Linked Retinitis Pigmentosa

full page →ctgov ↗

RECRUITINGphase readoutNCT07281118: Intercostal Cryoanalgesia in Double Lung Transplant Recipients

Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Post-operative Pain Management

full page →ctgov ↗

TERMINATEDphase readoutNCT04652518: LYT-100 in Post-acute COVID-19 Respiratory Disease

Sponsor: PureTech. Phase: PHASE2. Conditions: Covid19, Post-acute COVID-19 Respiratory Disease

full page →ctgov ↗

COMPLETEDphase readoutNCT07426497: Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia: A Randomized Controlled Trial

Sponsor: Istanbul Medeniyet University. Phase: NA. Conditions: Coccydynia, Chronic Pain, Coccygodynia

full page →ctgov ↗

SUSPENDEDphase readoutNCT06653010: Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer

Sponsor: Wondercel Biotech (ShenZhen). Phase: EARLY_PHASE1. Conditions: CRC (Colorectal Cancer), Metastatic Colorectal Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT05969860: At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma, Advanced Bladder Carcinoma, Advanced Breast Carcinoma, Advanced Carcinoid Tumor, Advanced Cervical Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastric Carcinoma, Advanced Glioblastoma, Advanced Head and Neck Carcinoma, Advanced HER2 Positive Breast Carcinoma, Advanced Lung Carcinoma, Advanced Lung Small Cell Carcinoma, Advanced Malignant Germ Cell Tumor, Advanced Malignant Solid Neoplasm, Advanced Neuroendocrine Carcinoma, Advanced Ovarian Carcinoma, Advanced Pancreatic Carcinoma, Advanced Prostate Small Cell Neuroendocrine Carcinoma, Advanced Prostate Carcinoma, Hematopoietic and Lymphoid System Neoplasm, Multiple Myeloma, Myelodysplastic Syndrome, Advanced Basal Cell Carcinoma, Advanced Cholangiocarcinoma, Advanced Endometrial Carcinoma, Advanced Esophageal Carcinoma, Advanced Fallopian Tube Carcinoma, Advanced Hepatocellular Carcinoma, Advanced Liver Carcinoma, Advanced Lymphoma, Advanced Malignant Testicular Neoplasm, Advanced Melanoma, Advanced Merkel Cell Carcinoma, Advanced Penile Carcinoma, Advanced Primary Malignant Central Nervous System Neoplasm, Advanced Renal Cell Carcinoma, Advanced Sarcoma, Advanced Skin Squamous Cell Carcinoma, Advanced Urethral Carcinoma, Advanced Vaginal Carcinoma, Advanced Vulvar Carcinoma, Advanced Appendix Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05544760: CatchU: A Quantitative Multisensory Falls-Assessment Study

Sponsor: Albert Einstein College of Medicine. Phase: NA. Conditions: Fall Injury, Age Problem, Well Aging, Sensory Disorders

full page →ctgov ↗

RECRUITINGphase readoutNCT05370820: Prevention of Postpartum Hemorrhage With Tranexamic Acid

Sponsor: Inova Health Care Services. Phase: PHASE2. Conditions: Post Partum Hemorrhage

full page →ctgov ↗

RECRUITINGphase readoutNCT01109420: Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Non-Medullary Thyroid Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06155682: TMS for Inhibition Enhancement in Schizophrenia

Sponsor: University of Maryland, Baltimore. Phase: NA. Conditions: Schizophrenia

full page →ctgov ↗

RECRUITINGphase readoutNCT07197424: The Use of Robot Assisted Magnetically Controlled Capsule Endoscopy in Patients With Iron Deficiency Anaemia

Sponsor: University of Edinburgh. Phase: NA. Conditions: Iron Deficiency Anaemia

full page →ctgov ↗

COMPLETEDphase readoutNCT06716424: A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus

Sponsor: Sanofi. Phase: PHASE4. Conditions: Type 2 Diabetes

full page →ctgov ↗

COMPLETEDphase readoutNCT04597424: Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)

Sponsor: ANRS, Emerging Infectious Diseases. Phase: PHASE3. Conditions: Unsafe Sex, Risk-Taking

full page →ctgov ↗

RECRUITINGphase readoutNCT04082520: Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Grade 1 Meningioma, Grade 2 Meningioma, Grade 3 Meningioma, Recurrent Meningioma, Unresectable Meningioma

full page →ctgov ↗

RECRUITINGphase readoutNCT05759923: First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours

Sponsor: Molecure S.A.. Phase: PHASE1. Conditions: Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma, Advanced Colorectal Carcinoma, Metastatic Pancreatic Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Renal Cell Carcinoma, Metastatic Ovarian Carcinoma

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07404423: OPEN-IPF: Observational Prediction modEl for cliNical Outcomes in Idiopathic Pulmonary Fibrosis

Sponsor: University of Modena and Reggio Emilia. Phase: . Conditions: Idiopathic Pulmonary Fibrosis

full page →ctgov ↗

RECRUITINGphase readoutNCT07559123: Imaging-based PRediction of Eligibility for ChemoImmunotherapy in reSEctable NSCLC, iPRECISE

Sponsor: Samsung Medical Center. Phase: . Conditions: NSCLC, Neoadjuvant Chemoimmunotherapy, CT

full page →ctgov ↗

COMPLETEDphase readoutNCT03899259: A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata

Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Alopecia Areata

full page →ctgov ↗

RECRUITINGphase readoutNCT06773780: Transcatheter Aortic Valve Implantation: Comparison of the Effects of Ultrasound-Guided Pericapsular Nerve Group Block and Fascia Iliaca Block on Postoperative Analgesia Management

Sponsor: Medipol University. Phase: NA. Conditions: Aortic Valve Stenosis, Transcatheter Aortic Valve Implantation, Pericapsular Nerve Group Block, Fascia Iliaca Block

full page →ctgov ↗

RECRUITINGphase readoutNCT06721455: Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery

Sponsor: Boston Children's Hospital. Phase: . Conditions: Heart Surgery, Blood Transfusion, Hemolysis

full page →ctgov ↗

COMPLETEDphase readoutNCT05339555: IUD Self-Removal Study

Sponsor: Oregon Health and Science University. Phase: NA. Conditions: IUD

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07644455: Percutaneous Biopsy After Neoadjuvant Chemotherapy.

Sponsor: Instituto do Cancer do Estado de São Paulo. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06260878: Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis

Sponsor: University of Calgary. Phase: PHASE4. Conditions: Post-ERCP Acute Pancreatitis

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05960578: Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study

Sponsor: University of Washington. Phase: PHASE2. Conditions: Metastatic Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8

full page →ctgov ↗

RECRUITINGphase readoutNCT07631078: kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery (KULMINATE) Pilot

Sponsor: Magnetic Tides. Phase: NA. Conditions: Stroke, Chronic Stroke Patients, Arm Weakness as a Consequence of Stroke

full page →ctgov ↗

COMPLETEDphase readoutNCT00611585: A Safety and Efficacy Study of the Birmingham Hip Resurfacing System

Sponsor: Smith & Nephew, Inc.. Phase: . Conditions: Arthritis

full page →ctgov ↗

COMPLETEDphase readoutNCT04163185: Initiating Early Control of Migraine Pain and Associated Symptoms

Sponsor: Axsome Therapeutics, Inc.. Phase: PHASE3. Conditions: Migraine

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03772743: Functional Assessment in Elderly MI Patients With Multivessel Disease

Sponsor: Consorzio Futuro in Ricerca. Phase: NA. Conditions: Myocardial Infarction

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04200443: Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Sponsor: City of Hope Medical Center. Phase: PHASE2. Conditions: Metastatic Leiomyosarcoma, Metastatic Soft Tissue Sarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8, Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8, Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8, Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8, Stage IV Uterine Corpus Leiomyosarcoma AJCC v8, Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8, Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8, Unresectable Leiomyosarcoma, Unresectable Soft Tissue Sarcoma

full page →ctgov ↗

Date TBD